Breast cancer vaccination: Latest advances with an analytical focus on clinical trials. 2023

Mahdi Kohansal Vajari, and Mohammad-Javad Sanaei, and Sina Salari, and Alireza Rezvani, and Mehrnaz Sadat Ravari, and Davood Bashash
Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Breast cancer (BC) is one of the main causes of cancer-related death worldwide. The heterogenicity of breast tumors and the presence of tumor resistance, metastasis, and disease recurrence make BC a challenging malignancy. A new age in cancer treatment is being ushered in by the enormous success of cancer immunotherapy, and therapeutic cancer vaccination is one such area of research. Nevertheless, it has been shown that the application of cancer vaccines in BC as monotherapy could not induce satisfying anti-tumor immunity. Indeed, the application of various vaccine platforms as well as combination therapies like immunotherapy could influence the clinical benefits of BC treatment. We analyzed the clinical trials of BC vaccination and revealed that the majority of trials were in phase I and II meaning that the BC vaccine studies lack favorable outcomes or they need more development. Furthermore, peptide- and cell-based vaccines are the major platforms utilized in clinical trials according to our analysis. Besides, some studies showed satisfying outcomes regarding carbohydrate-based vaccines in BC treatment. Recent advancements in therapeutic vaccines for breast cancer were promising strategies that could be accessible in the near future.

UI MeSH Term Description Entries
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations
D019496 Cancer Vaccines Vaccines or candidate vaccines designed to prevent or treat cancer. Vaccines are produced using the patient's own whole tumor cells as the source of antigens, or using tumor-specific antigens, often recombinantly produced. Cancer Vaccine,Neoplasm Vaccines,Tumor Vaccine,Tumor Vaccines,Vaccines, Cancer,Vaccines, Neoplasm,Vaccines, Tumor,Vaccine, Cancer,Vaccine, Tumor

Related Publications

Mahdi Kohansal Vajari, and Mohammad-Javad Sanaei, and Sina Salari, and Alireza Rezvani, and Mehrnaz Sadat Ravari, and Davood Bashash
June 2024, Life sciences,
Mahdi Kohansal Vajari, and Mohammad-Javad Sanaei, and Sina Salari, and Alireza Rezvani, and Mehrnaz Sadat Ravari, and Davood Bashash
November 2022, Immunological investigations,
Mahdi Kohansal Vajari, and Mohammad-Javad Sanaei, and Sina Salari, and Alireza Rezvani, and Mehrnaz Sadat Ravari, and Davood Bashash
April 2024, Cell biochemistry and function,
Mahdi Kohansal Vajari, and Mohammad-Javad Sanaei, and Sina Salari, and Alireza Rezvani, and Mehrnaz Sadat Ravari, and Davood Bashash
November 2018, Clinical cancer research : an official journal of the American Association for Cancer Research,
Mahdi Kohansal Vajari, and Mohammad-Javad Sanaei, and Sina Salari, and Alireza Rezvani, and Mehrnaz Sadat Ravari, and Davood Bashash
February 2023, The Surgical clinics of North America,
Mahdi Kohansal Vajari, and Mohammad-Javad Sanaei, and Sina Salari, and Alireza Rezvani, and Mehrnaz Sadat Ravari, and Davood Bashash
May 2019, Expert opinion on biological therapy,
Mahdi Kohansal Vajari, and Mohammad-Javad Sanaei, and Sina Salari, and Alireza Rezvani, and Mehrnaz Sadat Ravari, and Davood Bashash
June 2013, Breast (Edinburgh, Scotland),
Mahdi Kohansal Vajari, and Mohammad-Javad Sanaei, and Sina Salari, and Alireza Rezvani, and Mehrnaz Sadat Ravari, and Davood Bashash
January 2015, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting,
Mahdi Kohansal Vajari, and Mohammad-Javad Sanaei, and Sina Salari, and Alireza Rezvani, and Mehrnaz Sadat Ravari, and Davood Bashash
December 2016, Contemporary clinical trials communications,
Mahdi Kohansal Vajari, and Mohammad-Javad Sanaei, and Sina Salari, and Alireza Rezvani, and Mehrnaz Sadat Ravari, and Davood Bashash
October 2017, Surgical oncology clinics of North America,
Copied contents to your clipboard!